News

Insights into SBM Offshore's Recent Share Repurchase Program

Insights into SBM Offshore's Recent Share Repurchase Program

Understanding SBM Offshore's Share Repurchase Program

SBM Offshore has disclosed significant updates regarding its share repurchase initiative, which is a strategic approach contributing to the company's long-term growth and investor engagement. As part of this program, the company has committed to repurchasing shares amounting to approximately EUR141 million throughout the stated periods.

Transaction Details of the Share Repurchase

According to reports, the share buyback took place from August 14 to August 20 within a broader initiative effective since April 24. The underlying aim of this repurchase is to reduce share capital while also providing funds for employee management and share schemes.

Progress Overview

During the outlined period, here are some key figures from the share repurchase program:

  • Total Repurchase Amount: EUR 141,189,019
  • Cumulative Repurchase Amount: EUR 54,427,645
  • Cumulative Quantity Repurchased: 2,574,029 shares
  • Cumulative Average Repurchase Price: EUR 21.14
  • Percentage of Program Completed: 38.55%

Recent Trading Days Summary

Here’s a brief look at the latest trading days corresponding to share repurchases:

Trade Date Quantity Repurchased Average Purchase Price Settlement Amount
August 14, 2025 29,219 EUR 22.28 EUR 650,999
August 15, 2025 28,996 EUR 22.45 EUR 650,980
August 18, 2025 28,854 EUR 22.56 EUR 650,981
August 19, 2025 28,223 EUR 23.07 EUR 650,997
August 20, 2025 26,714 EUR 22.93 EUR 612,445

SBM Offshore: A Closer Look

SBM Offshore continues to assert its place as a leader in deepwater and floating facility infrastructure. The firm specializes in designing, constructing, and operating offshore infrastructures, actively contributing to cleaner energy solutions and forging pathways in the blue economy.

Corporate Communications

Investors can stay informed about the status of the share repurchase program, alongside latest updates, by checking the Investor Relations section on the company's website. This transparency builds trust and supports shareholder confidence in SBM Offshore’s strategic decisions and operational performance.

Frequently Asked Questions

What is the purpose of the share repurchase program?

The share repurchase program aims to reduce share capital and offer shares for employee management schemes.

How much has been repurchased under this program?

Thus far, EUR141 million worth of shares have been repurchased, totaling 2,574,029 shares.

What was the cumulative average purchase price?

The average purchase price was EUR 21.14 for the cumulative repurchased shares.

When did the share repurchase program commence?

The program began on April 24, 2025, and is designed to continue providing updates as transactions unfold.

Where can investors find more information about SBM Offshore?

Investors can access comprehensive information through the company's official website, particularly in the Investor Relations section.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Midterm Election Insights: Border Enforcement Debate Heats Up

Updated Category News Views 153

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Continue Reading
Cognex Delivers Record Q3 Results, Eyes Future Growth

Updated Category News Views 107

Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...

Continue Reading
Breeze Airways Secures $228M for Fleet Expansion

Updated Category News Views 58

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

Continue Reading
NIH Seeks AI Solutions for Kidney Disease Breakthroughs

Updated Category News Views 83

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Continue Reading
Cooper Standard Faces Challenges Despite New Business Wins

Updated Category News Views 156

Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...

Continue Reading
Truelink's Strategic Expansion: GES Acquires CSG Creative

Updated Category News Views 31

Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...

Continue Reading
PSG's Anna AI Wins Vizient's Innovative Tech Nod

Updated Category News Views 79

Hospital Hiring Gets a Tech Boost In the bustling world of healthcare recruitment, it's like trudging through quicksand with a time bomb strapped to your back. That's where PSG Global Solutions sauntered into the Las Vegas spotlight with Anna AI, their generative AI marvel that just snagged the Innovative Technology designation from Vizient. This ain’t your...

Continue Reading
Cogent's Q3 2026: A Mixed Bag of Financial Moves

Updated Category News Views 110

Cogent Communications' Latest Quarter Insights When you hitch your wagon to the communications and internet industry, there's no escaping the hard truths from meticulous quarterly reports. Take Cogent Communications' latest Q3 2026 results, where numbers speak louder than words. Service revenue dipped to $231.2 million for the quarter, a 1.8% drop compared to Q2. And...

Continue Reading
Fosun's Strategic Innovations Unveiled at CIIE 2026

Updated Category News Views 108

Fosun's Nine-Year CIIE Journey Fosun's been trotting out its innovations at the China International Import Expo (CIIE) for nine straight years. With 162 countries in the mix this time around, they're not just playing house—it’s downright world-class boasting. Fosun’s rolling out their hard-hitters in the medical tech space, showing they’re no rookies to the...

Continue Reading
Marini SkinSolutions Wins with Night Zyme Complex

Updated Category News Views 89

Shaking Up the Skincare Scene You don't often see a skincare product snag three prestigious awards in one year, but that's exactly what's unfolding for Marini SkinSolutions. This time, their Night Zyme® Overnight Glass Skin Resurfacing Complex grabbed the 2026 Shop TODAY Ageless Beauty Award. It’s turning heads and not just in beauty aisles but among investors eyeing a...

Continue Reading

Top 5 Most Recently Viewed Articles

Boldyn Networks Achieves Major Player Status in Private 5G Market

Updated Category News Views 163

Boldyn Networks Achieves Major Recognition in Private 5G Sector Boldyn Networks, a global leader in private networks and shared communications infrastructure, has made waves in the telecommunications industry with its recent recognition as a Major Player in the IDC MarketScape: European Enterprise Private 5G Solutions 2025 Vendor Assessment. This validation reflects...

Continue Reading
LinkSquares Debuts All-Agentic CLM Platform for Legal Teams

Updated Category News Views 16

LinkSquares: A Game Changer for Contract Management In the world of legal and business operations, few things eat away at patience—let alone profits—like the cumbersome dance of contract management. Enter LinkSquares, strutting onto the stage with its new all-agentic CLM platform, promising to turn this often painful process into a streamlined operation that saves...

Continue Reading
Sanctuary Medicinals Triumphs at NECANN Cup with Recognition

Updated Category News Views 216

Sanctuary Medicinals Shines at NECANN Cup Boston 2025 Sanctuary Medicinals proudly celebrates a remarkable achievement at the 6th Annual NECANN Cup Boston. The company earned the impressive title of 4th place in the competitive Solvent Concentrates category. This accolade showcases Sanctuary Medicinals' unwavering commitment to excellence, innovation, and quality within...

Continue Reading
Patients Continue Obesity Treatments as Coverage Shrinks

Updated Category News Views 174

The Growing Challenge of Obesity Drug Coverage For many individuals battling obesity, the struggle is not just about losing weight. It’s also about bearing the financial burden of treatments. With increasing limitations from insurers regarding weight-loss drugs, patients are often forced to alter their lifestyles significantly. Vacations are postponed, dining out is...

Continue Reading
Humacyte, Inc. Investors Urged to Act Before Class Action Deadline

Updated Category News Views 123

Important Attention for Humacyte, Inc. Investors As an investor in Humacyte, Inc., it’s essential to stay informed about legal opportunities that could impact your investments. The Rosen Law Firm, known for its dedication to protecting investor rights, is reminding those who purchased Humacyte securities during a specified period about an important upcoming deadline....

Continue Reading